Subsequently, we established a FRPM, consisting of four prognostic genes (SLC7A11, SLC1A5, GCLM and SAT1), to evaluate the survival of HCC patients, based on which, patients were divided into high‐risk group and low‐risk group. This evidence concerns the gene SLC1A5 and hepatocellular carcinoma.